Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polymerase theta helicase (Polθ helicase) is a specialized domain within the DNA polymerase theta (Polθ, gene symbol POLQ), an enzyme critical for theta-mediated end joining (TMEJ). It is a superfamily II helicase, playing a role in DNA binding and annealing at double-strand breaks to facilitate error-prone DNA repair via microhomology search. It is upregulated in some cancers, making it a potential therapeutic target.
Inhibition of helicase and/or polymerase activity; disruption of TMEJ
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polymerase Theta Helicase (None).